Compile Data Set for Download or QSAR
Report error Found 101 Enz. Inhib. hit(s) with all data for entry = 1592
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159226(US9682967, 44 | US10195186, Example 46)
Affinity DataKi:  84nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159226(US9682967, 44 | US10195186, Example 46)
Affinity DataIC50: 88nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445042(CHEMBL3098767 | US9682967, 7 | US10195186, Example...)
Affinity DataKi:  162nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445042(CHEMBL3098767 | US9682967, 7 | US10195186, Example...)
Affinity DataIC50: 170nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445055(CHEMBL3098744 | US9682967, 43 | US10195186, Exampl...)
Affinity DataKi:  190nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445055(CHEMBL3098744 | US9682967, 43 | US10195186, Exampl...)
Affinity DataIC50: 200nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Mouse)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataKi:  210nMAssay Description:The Sortilin assay was performed in total volume of 40 μl in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Mouse)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 220nMAssay Description:The Sortilin assay was performed in total volume of 40 μl in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159140(US9682967, 18 | US10195186, Example 18)
Affinity DataKi:  229nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159140(US9682967, 18 | US10195186, Example 18)
Affinity DataIC50: 240nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 260nMAssay Description:The pro Sortilin assay was performed in total volume of 20 μl in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159213(US9682967, 42 | US10195186, Example 44)
Affinity DataKi:  286nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159213(US9682967, 42 | US10195186, Example 44)
Affinity DataIC50: 300nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159138(US9682967, 16 | US10195186, Example 16)
Affinity DataKi:  343nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159139(US9682967, 17 | US10195186, Example 17)
Affinity DataKi:  343nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159138(US9682967, 16 | US10195186, Example 16)
Affinity DataIC50: 360nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159139(US9682967, 17 | US10195186, Example 17)
Affinity DataIC50: 360nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataKi:  429nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 450nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159123(US9682967, 11 | US10195186, Example 11)
Affinity DataKi:  457nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159129(US9682967, 13 | US10195186, Example 13)
Affinity DataKi:  457nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159178(US9682967, 32 | US10195186, Example 34)
Affinity DataKi:  467nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159129(US9682967, 13 | US10195186, Example 13)
Affinity DataIC50: 480nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159123(US9682967, 11 | US10195186, Example 11)
Affinity DataIC50: 480nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159178(US9682967, 32 | US10195186, Example 34)
Affinity DataIC50: 490nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159154(US9682967, 23 | US10195186, Example 23)
Affinity DataKi:  543nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159154(US9682967, 23 | US10195186, Example 23)
Affinity DataIC50: 570nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159272(US9682967, 48 | US10195186, Example 50)
Affinity DataKi:  599nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159273(US9682967, 49 | US10195186, Example 51)
Affinity DataKi:  614nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159272(US9682967, 48 | US10195186, Example 50)
Affinity DataIC50: 620nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159273(US9682967, 49 | US10195186, Example 51)
Affinity DataIC50: 640nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159121(US9682967, 9 | US10195186, Example 9)
Affinity DataKi:  667nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159121(US9682967, 9 | US10195186, Example 9)
Affinity DataIC50: 700nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445044(CHEMBL3098765 | US9682967, 34 | US10195186, Exampl...)
Affinity DataKi:  714nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445041(CHEMBL3098768 | US9682967, 46 | US10195186, Exampl...)
Affinity DataKi:  721nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159271(US9682967, 47 | US10195186, Example 49)
Affinity DataKi:  734nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159271(US9682967, 47 | US10195186, Example 49)
Affinity DataIC50: 750nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445044(CHEMBL3098765 | US9682967, 34 | US10195186, Exampl...)
Affinity DataIC50: 750nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445041(CHEMBL3098768 | US9682967, 46 | US10195186, Exampl...)
Affinity DataIC50: 760nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445051(CHEMBL3098752 | US9682967, 5 | US10195186, Example...)
Affinity DataKi:  790nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445051(CHEMBL3098752 | US9682967, 5 | US10195186, Example...)
Affinity DataIC50: 830nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM332002(US10195186, Example 31 | 5-Bromo-N-(6-methyl-pyrid...)
Affinity DataKi:  924nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159146(US9682967, 20 | US10195186, Example 20)
Affinity DataKi:  943nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159117(US9682967, 8 | US10195186, Example 8)
Affinity DataKi:  952nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM332002(US10195186, Example 31 | 5-Bromo-N-(6-methyl-pyrid...)
Affinity DataIC50: 970nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159146(US9682967, 20 | US10195186, Example 20)
Affinity DataIC50: 990nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159117(US9682967, 8 | US10195186, Example 8)
Affinity DataIC50: 1.00E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159210(US9682967, 41 | US10195186, Example 43)
Affinity DataKi:  1.05E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159210(US9682967, 41 | US10195186, Example 43)
Affinity DataIC50: 1.10E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445058(CHEMBL3098741 | US9682967, 2 | US10195186, Example...)
Affinity DataKi:  1.14E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: